Our personalized approach ensures that your unique needs and health goals remain the focus of your treatment plan
Regular follow-up appointments are essential during GLP-1 therapy, typically aligning with the medication's titration schedule (often every 4 weeks initially) and as clinically indicated
Mounjaro is approved for individuals with type 2 diabetes, while Zepbound is approved for weight loss and obstructive sleep apnea in people with obesity. Pretty much everything else between these two medications is the same
Internationally, the code for the corresponding diagnosis may differ
CJC-1295/Ipamorelin has been shown to stimulate protein synthesis, which leads to increase muscle growth, muscle fiber density, and thus, strength
People with a personal or family history of medullary thyroid carcinoma (MTC) or who have multiple endocrine neoplasia syndrome type 2 (MEN 2) should not take Wegovy